Table 2.
Univariate and multivariate analysis of factors associated with Pneumocystis jirovecii detection in non-immunosuppressed infants at risk for Pneumocystis primary infection.
| Variable | Adjusted odds ratio | 95% CI | P-value |
|---|---|---|---|
| Univariate analysis | |||
| Age quartile | |||
| no. 3 (n = 47; 63–189 days) | 42.2 | 5.4-332 | <.001 |
| no. 4 (n = 48; 190–729 days) | 9.6 | 1.15-80 | .037 |
| 90 ≤ age <120 days | 51 | 1.7-1498 | .023 |
| Hyaline membrane disease and/or bronchopulmonary dysplasiaa | 0.3 | 0.1-0.8 | .019 |
| Congenital disease | 2.4 | 1.1-5.6 | .037 |
| Viral coinfection | 2.2 | 1.1-4.7 | .035 |
| Lower respiratory tract infection | 2.5 | 1.1-5.9 | .032 |
| Absence of hospital discharge after birtha,b | 0.1 | 0.02-0.5 | .003 |
| Multivariate analysis | |||
| Age quartile no. 3 (n = 47; 63–189 days) | 11.5 | 2.1-63.5 | .005 |
| Absence of hospital discharge after birtha,b | 0.1 | 0.02-0.72 | .02 |
CI, confidence interval.
anegatively associated with P. jirovecii; bsome newborns and infants were hospitalized after birth and discharge of their mothers.